Interestingly, in our study, we found that hydrogen treatment actually alleviated ROS in CAFs and down‐regulated a key ROS‐induced gene, Nos2, and down‐stream pro‐tumor factors such as Mmp2, Cxcl1, and Cxcl12. The gene discussed is CXCL1; the disease is neoplasm.